New York, NYNCT06656351Now EnrollingIRB Ready

Chronic Babesiosis Clinical Trial in New York, NY

Access cutting-edge chronic babesiosis treatment through this phase 2 clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by 60 Degrees Pharmaceuticals LLC

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access chronic babesiosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic babesiosis treatment provided free

Apply for This New York Location

Check if you qualify for this chronic babesiosis clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Chronic Babesiosis Study in New York

Phase 2 Open Label Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue

Sponsor: 60 Degrees Pharmaceuticals LLC

Who Can Participate

Inclusion Criteria

Male or female, aged ≥ 18 years
Severe disabling fatigue
Have at least one common symptom of babesiosis
Have laboratory evidence of exposure to babesia in the last 12 months
Able and willing to give written informed consent
Able and willing to perform all study assessments
If female negative urine pregnancy test and
If female agree to use an acceptable method of birth control

Exclusion Criteria

Glucose-6-phosphate-dehydrogenase (G6PD) deficiency
Breastfeeding
Unmanaged Psychotic disorder
Known hypersensitivity reaction to tafenoquine or other 8-aminoquinolines
Current or planned treatment with quinine
Uncontrolled cardiopulmonary or endocrine disorders
Taking OCT2/MATE substrates without appropriate medical oversight
Medical history of chronic, active viral diseases including HIV/AIDS, hepatitis B, and hepatitis C
Have a risk factors for relapsing babesiosis
Any concomitant significant illness unrelated to babesiosis
The patient is unable to tolerate medication by the oral route
The patient has previously taken tafenoquine
Hemoglobin at baseline is ≤ 8 g/dL

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06656351) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Babesiosis Treatment Options in New York, NY

If you're searching for chronic babesiosis treatment options in New York, NY, this clinical trial (NCT06656351) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced chronic babesiosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic babesiosis clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in New York, NY

See all interstitial cystitis clinical trials recruiting in New York — not just this study.

Browse Interstitial Cystitis Trials in New York →

Browse More Trials by Condition

Interstitial Cystitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY